National Medical Insurance Bureau: Expand payment channels for Innovative Drugs and guide benefit-oriented commercial health Insurance to include Innovative Drugs in the coverage responsibilities.

On January 9, 2024, the National Healthcare Security Administration held a symposium to support the development of Innovative Drugs, communicating with several pharmaceutical companies about the progress of Innovative Drugs and listening to their opinions and suggestions regarding support from the healthcare insurance department.

Zhitong FinanceJan 13 11:17

China Securities Co.,Ltd.: An outlook on the pharmaceutical Industry 2024 annual report.

In 2025, the Industry is expected to achieve moderate growth and overall move towards high-quality development.

Zhitong FinanceJan 13 09:37

Guoyuan Securities 2025 CSI SWS Health Care index investment strategy report: Bullish on innovation and overseas expansion, focusing on upward fundamental segmentation tracks.

The international expansion of the pharmaceutical industry remains an essential path for our country's pharmaceutical companies in the future, and companies with strong product capabilities and channel capabilities are expected to gain an advantage.

Zhitong FinanceJan 10 10:20

Pharmaceutical stocks have become a transitional theme at present, and the performance line may be further valued by the market.

Track the entire lifecycle of the main sector.

cls.cnJan 7 09:20

How is the quality and supply of Pharmaceuticals guaranteed? The National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals.

On December 26, 2024, the National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals, inviting representatives from the National Medical Products Administration, selected Pharmaceutical enterprises, and research Institutions to communicate and exchange views on recent societal concerns regarding quality assurance of centrally procured Pharmaceuticals and innovative development in the Industry, and to listen to opinions and suggestions.

Zhitong FinanceDec 30, 2024 13:32

JILIN CHANGLONG (08049) subscribes to 20 million yuan financial products.

JILIN CHANGLONG (08049) announced that on December 27, 2024, the company will recognize...

Zhitong FinanceDec 27, 2024 16:37